September 23, 2008
PHILADELPHIA - Researchers at The Johns Hopkins University School of Medicine in Baltimore have developed a novel test to screen for chemical modifications to DNA known as methylation. The technology potentially could be used both for early cancer diagnoses and for assessing patients' response to cancer therapies. To read more of this article, click here: http://www.aacr.org/home/public--media/news.aspx?d=1130
Tuesday, September 30, 2008
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment